从免疫平衡到瘤生态动力学
1State Key Laboratory of Respiratory Disease, Center for Infection and Immunity, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Frontiers in oncology
|May 29, 2024
概括
一个新的理论,瘤生态动力学,量化地描述了瘤生态系统及其相互作用. 该框架为评估癌症免疫疗法的疗效建立了新的标准,超越了传统的指标.
科学领域:
- 在瘤学瘤学.
- 系统生物学 系统生物学
- 免疫学 免疫学 免疫学
背景情况:
- 复杂的瘤生态系统缺乏定量描述理论.
- 目前的癌症免疫疗法疗效评估方法不足.
- 需要先进的瘤特征和评估标准.
研究的目的:
- 建立一种用于定量性瘤生态系统描述的新理论.
- 创新瘤特征的方法.
- 制定癌症免疫疗法的新疗效评估标准.
主要方法:
- 应用逆免疫力学,适应免疫平衡理论.
- 开发瘤生态动力学方程使用物理概念,如动量.
- 引入了针对活动-体积等效的调整瘤动量方程.
主要成果:
- 建立了瘤生态动力学方程和瘤生态势头.
- 不同的疾病进展,伪进展和超进展.
- 为固体瘤免疫治疗提出了新的疗效评估标准 (ieRECIST).
结论:
- 介绍了瘤生态动力学,这是一个结合瘤活动和体积的理论.
- 这一新框架解决了瘤生态系统的基本和应用问题.
- 预测了癌症免疫生态治疗的兴起,针对整个瘤生态系统.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


